entinostat (SNDX-275) - Kyowa Hakko Kirin, Syndax
Entinostat: Regulatory approval for breast cancer in Q2 2021 (Syndax) - Feb 6, 2020 - Corporate Presentation 
Regulatory
http://ir.syndax.com/static-files/ec1ddcca-2728-4880-ae53-9900a088c844
 
Feb 6, 2020
 
 
ce480253-4d29-4b20-a39b-b6bcd16d6eba.jpg